- Home
- » Tags
- » Succinimide
Top View
- Drug/Substance Trade Name(S)
- 2-Pyrrolidinone and Succinimide As Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-Seizure Medications Impact Accurate Diagnosis
- Xerox University Microfilms 300 North Zeeb Road Ann Arbor, Michigan 48106 73-30,250
- The Selection and Use of Essential Medicines
- The Epilepsy Prescriber's Guide to Antiepileptic Drugs
- Council of Europe Committee of Ministers (Partial
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- Chemical Safety and Waste Management Manual
- Customs Tariff - Schedule
- United States Patent 1C6 Patented Jan
- Protocol Use of Antidepressants and Risk of Hip/Femur Fracture
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Hazardous Materials
- Wo 2007/044693 A2
- N-Bromosuccinimide - Wikipedia
- (12) Patent Application Publication (10) Pub. No.: US 2004/0167287 A1 Kozlowski Et Al
- Docking Studies of Phthalimide Pharmacophore As a Sodium Channel Blocker
- ATC Codes…. (Pdf)
- Drug Repurposing to Treat Glucocorticoid Resistance in Asthma Alberta L
- Sills, G. J. and Rogawski, M. A. (2020) Mechanisms of Action of Currently Used Antiseizure Drugs
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Guidelines for ATC Classification and DDD Assignment 2021
- Guidelines for ATC Classification and DDD Assignment 2011
- Preparation of Cyclic Imides from Alkene-Tethered Amides: Application of Homogeneous Cu(II) Cite This: RSC Adv., 2020, 10, 7698 Catalytic Systems†
- ICADTS Drug List
- Ir Force Base Outpatient Formulary Alphabetical Listing by Name Eglin A
- Alphabetical Listing by Name Naval Hospital Jacksonville Formulary
- M/S. AWAKE CHEMICALS PVT. LTD. Survey No
- Harmonized Tariff Schedule of the United States (2006) (Rev
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- International Classification of Procedures in Medicine
- Epilepsy (1 of 26)
- Chemical Waste Registry – Updated 4/4/13
- Engineering Cocrystals of Poorly Water-Soluble Drugs to Enhance Dissolution in Aqueous Medium
- Resolution Ap (2000) 1
- Redox Systems for Brain-Targeted Drug Delivery
- Metabolomics Identifies a Biomarker Revealing in Vivo Loss of Functional ß-Cell Mass
- Pharmacokinetics, Brain Distribution and Plasma Protein Binding of Carbamazepine and Nine Derivatives: New Set of Data for Predictive in Silico ADME Models